Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow AbbVie Inc.

Get SEC filing alerts via email and in your feed for AbbVie Inc.

ABBV

AbbVie Inc.

About AbbVie Inc.

AbbVie Inc. is a global biopharmaceutical company focused on researching, developing, manufacturing, and marketing innovative therapies across immunology, oncology, aesthetics, neuroscience, and eye care. Its diverse product portfolio addresses complex diseases with leading biologics and pharmaceuticals, serving healthcare providers, payers, and patients worldwide. AbbVie’s integrated business model combines advanced R&D, global supply chain, and targeted commercialization to deliver specialized medicines and medical devices in major international markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from AbbVie Inc.

1
1
AbbVie Inc. AbbVie Reports 12% Revenue Growth to $15.0 Billion in Q1 2026

Via official filing (AI summary) | 28 days ago | 0 comments

2
1
AbbVie Inc. AbbVie Reports $61.2 Billion in Revenue for Fiscal Year 2025, Driven by Immunology Growth

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
AbbVie Inc. AbbVie Reports Q3 2025 Revenue Growth to $15.8 Billion, Net Earnings Decline

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
AbbVie Inc. AbbVie Reports $15.4 Billion in Q2 2025 Revenues, Faces Decline in Net Earnings

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
AbbVie Inc. AbbVie Reports $13.3 Billion in Q1 2025 Revenues, Acquires Nimble Therapeutics

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
AbbVie Inc. AbbVie Reports $56.3 Billion in Revenue for Fiscal Year 2024, Driven by Immunology Sales

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
AbbVie Inc. AbbVie Reports 3.8% Revenue Growth, Operating Earnings Surge in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments